Latest on the COVID-19 Situation

In response to the coronavirus pandemic, ZEISS has taken comprehensive measures to protect employees and maintain smart business continuity.

In order to continue supporting customers and partners as best as possible, at ZEISS we are doing everything we can to protect our employees’ health and safety as well as maintain production in our plants and ensure our service operations.

In January, ZEISS set up a dedicated task force. We are closely assessing the latest developments together with government agencies and healthcare authorities on an ongoing basis. Decisions are made daily regarding the most sensible measures for ZEISS to take.

Of course, we will continue to be available for our customers as best we can. Some employees in individual areas are currently working remotely but can still be reached at their usual phone numbers and email addresses.

However, should our customers experience any disruptions in service at some of our sites and sales offices, we can also be contacted on these numbers.

All over the world, the company and its employees are joining the fight against the spread and consequences of the coronavirus pandemic. Read more

ZEISS Group

Solutions that shape technological progress

Diagnose & Treat

Researching into Micro- and Nanostructures

See better

Assure Industrial Quality Excellence

Enabling Chip Manufacturers

Photograph & Film

Discover ZEISS

Fascinating insights into the world of optics

ZEISS SmartLife Lenses

New Light Sheet Fluorescence Microscope – ZEISS Lightsheet 7

From Energy to eMotion

3D Printed Microstructures Made Easy

News & Events

News from the ZEISS Group

19 May 2020

Half-Year Figures: ZEISS Looks back on Good First Six Months Overall

Press Release

Overall, the first six months of fiscal year 2019/20 went well for the ZEISS Group. It saw its revenue rise by 6 percent (compared to 3 percent) to EUR 3.213 billion. At EUR 455 million, earnings before interest and tax (EBIT) were slightly higher than the previous year (EUR 443 million). The EBIT margin was at 14.2%. Incoming orders hit EUR 3.601 billion.

11 May 2020

Carl Zeiss Meditec increases revenue in first six months of 2019/20

Press Release

Carl Zeiss Meditec AG

Carl Zeiss Meditec generated revenue of €714.9m in the first six months of 2019/20 (prior year: €667.2m), achieving growth of 7.2% (adjusted for currency effects: +5.8%) compared with the same period of the prior year.

20 April 2020

Jian-Wei Pan to Receive ZEISS Research Award

Press Release

Jian-Wei Pan, Professor at the University of Science and Technology of China, in Hefei, is the winner of the prestigious ZEISS Research Award 2020.